Galvita AG

Galvita AG is a pioneering force in biotechnology research, dedicated to advancing drug delivery systems. With a focus on innovation and excellence, Galvita AG introduces its groundbreaking TIP-Technology for Orally Disintegrating Tablets (ODTs). This revolutionary, patented technology enables the creation of micro capsules (Templated Inverted Particles / TIP) that can be loaded with diverse active ingredients and easily compressed into tablets, boasting exceptional mechanical strength.

The unique attributes of TIP-based tablets from Galvita AG offer numerous advantages over conventional oral dosage forms, including ultra-rapid disintegration (5-10 seconds), a swift onset of action (reduced first-pass effect), water-free ingestion (eliminating the need for swallowing), smaller tablet sizes, effective taste masking, and a neutral product composition (100% pure calcium phosphate TIP, compendial and inorganic material). Galvita AG is located at Mattenstrasse 22, Basel, 4058, CH. The company offers licensing of its patented technology and provides value-added services in formulation development, encompassing feasibility/early formulation, R&D, and scale-up support. Additionally, Galvita AG assists in establishing and conducting clinical testing and studies.

Galvita AG is committed to driving advancements in the pharmaceutical industry through its cutting-edge technology and comprehensive services. We invite the manager of Galvita AG to create a customized and exclusive company showcase and product listing on our platform to further amplify their reach and impact.